Now that the federal government is recommending that many COVID-vaccinated Americans receive booster shots starting this fall, it’s important to know what a “booster” is and how it differs from a ...

Eighteen months after US trial participants received a primary dose of Valneva's Lyme disease vaccine candidate (VLA15), a ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The Centers for Disease Control and Prevention is issuing new advice for people who are immunocompromised. The health organization said people who've had the MRNA vaccines should look to get a fourth ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...

WASHINGTON -- People with certain health conditions that make them moderately or severely immunocompromised may get a fourth mRNA COVID-19 shot, according to updated guidelines from the US Centers for ...

Takeda has announced the completion of its 7-year, Phase III TIDES clinical trial (NCT02747927) evaluating the dengue vaccine, Qdenga. Along with an exploratory analysis of a booster dose, TIDES data ...